Rymedi provides patient and population health data management software for diagnostic testing, clinical research, and employee health services in the life sciences sector.

Rymedi

We provide blockchain enabled patient and population healthcare data management software which supports:
• Diagnostic and toxicology testing devices companies
• Clinical trials and registries
• Laboratory integrations
• Secure storage of patient and population healthcare data

How does Rymedi empower life sciences companies to improve human health? See the video below on how our blockchain-enabled technology supports clinical research for better patient outcomes. 

Are you a study sponsor or CRO that would like more information? Request a demo today or start the conversation with us. www.rymedi.com/contact-us 

#clinicalresearch #healthcaretechnology #precisionmedicine #web3 #desci #blockchain #medicalresearch #clinicaltrial

David Stefanich, Jason Cross, Elizabeth Yarbrough, Steve Clemons, Scott Bowden, Jim Bickelhaupt, Mark Elfers, Deepak H., Charlie Jordan, Nancy Greer, Armando A., Omar Al Gburi, Aditya Tatipaka, Sergii Babikov, Vi Huynh, Kristina Loughrey, SCbio

Great news for healthcare sectors!! Rymedi is expanding its cutting-edge web3 healthcare solutions to US and global locations using 3-tier Avalanche Subnet architecture with Zeeve’s top-notch appchain infra underneath.⚕️Here's more details... 

Healthcare innovation is set to climb its peak with Rymedi's groundbreaking use of Web3 technology. Leveraging a unique 3-tier Avalanche hashtag#subnet architecture, Rymedi is seamlessly processing millions of transactions and patient data while ensuring next-level scalability.

✨Partnering with Zeeve, they've ensured top-notch Subnet performance and reliability with enterprise-grade infrastructure optimized with 99.9% Enterprise SLA & 24/7 support.
 
Read more about Rymedi’s unparalleled expansion here - https://lnkd.in/gw6Faf-q

#HealthcareInnovation #Web3 #Blockchain #Avalanche #TechNews #HealthTech #DataManagement #GlobalExpansion #Rymedi #Zeeve

Reposted from our Partner Zeeve. 

Great news for healthcare sectors!! Rymedi is expanding its cutting-edge web3 healthcare solutions to US and global locations using 3-tier Avalanche Subnet architecture with Zeeve’s top-notch appchain infra underneath.⚕️Here's more details... 

Healthcare innovation is set to climb its peak with Rymedi's groundbreaking use of Web3 technology. Leveraging a unique 3-tier Avalanche hashtag#subnet architecture, Rymedi is seamlessly processing millions of transactions and patient data while ensuring next-level scalability.

✨Partnering with Zeeve, they've ensured top-notch Subnet performance and reliability with enterprise-grade infrastructure optimized with 99.9% Enterprise SLA & 24/7 support.
 
Read more about Rymedi’s unparalleled expansion here - https://lnkd.in/gw6Faf-q

hashtag

#HealthcareInnovation hashtag
#Web3 hashtag
#Blockchain hashtag
#Avalanche hashtag
#TechNews hashtag
#HealthTech hashtag
#DataManagement hashtag
#GlobalExpansion hashtag
#Rymedi hashtag
#Zeeve

Excited to be mentioned in this article about active DeSci crypto projects, and  the key sectors poised to benefit from DeSci that shake up how research is conducted to help everyone.  

https://lnkd.in/e-69mxCs

#Crypto #DeSci, #Blockchain, Jason Cross, David Stefanich, Nina Kilbride, Joseph W. Bruzzesi, Cameron Coombes, Jim Bickelhaupt Matthew Immerso Jelani Clarke Ph.D. Subu Ramachandran Blockchange Ventures  Jose Arrieta Jason Cordeiro

Leadership Spotlight: Jim Bickelhaupt . Jim is the Vice President of Product and Technology at Rymedi bringing years of experience and invocation to the team. Learn about him in the Q and A below! 

𝐂𝐚𝐧 𝐲𝐨𝐮 𝐠𝐢𝐯𝐞 𝐮𝐬 𝐚𝐧 𝐨𝐯𝐞𝐫𝐯𝐢𝐞𝐰 𝐨𝐟 𝐲𝐨𝐮𝐫 𝐜𝐚𝐫𝐞𝐞𝐫 𝐚𝐧𝐝 𝐡𝐨𝐰 𝐲𝐨𝐮 𝐠𝐨𝐭 𝐭𝐨 𝐑𝐲𝐦𝐞𝐝𝐢?
Right out of MBA School at Auburn University, I started writing software for a large lighting manufacturer. Within 2 years I was leading a team of software developers writing custom solutions for a private label company. They decided to implement an ERP system and I got my first exposure to building and implementing SAP’s ERP software. After becoming an SAP certified developer and getting real experience implementing SAP from the ground up, I joined Coca-Cola to help build their SAP solution. By the time I left Coca-Cola after 16 years, I’d lead the development organization, served as regional CIO for Coca-Cola South Pacific, and traveled the world delivering SAP and a host of other software solutions. Prior to Rymedi, I worked for Tiffany & Co in NYC leading their IT transformation program that included new capabilities for all facets of the business. Wanting to be closer to family, we relocated to Greenville SC. I met our founders David and Jason and was hooked on their vision and what they were building and joined Rymedi in late 2023.

𝐂𝐚𝐧 𝐲𝐨𝐮 𝐠𝐢𝐯𝐞 𝐮𝐬 𝐲𝐨𝐮𝐫 𝐠𝐫𝐞𝐚𝐭𝐞𝐬𝐭 𝐜𝐚𝐫𝐞𝐞𝐫 𝐚𝐜𝐜𝐨𝐦𝐩𝐥𝐢𝐬𝐡𝐦𝐞𝐧𝐭?
I led a larger SAP upgrade for Coca-Cola that encompassed a huge version change as well as significant business capability changes. After 9 months of long days and nights we cutover to the new platform over a 36 hour whirlwind weekend. I came home at 3 am and woke up a few hours later to a text from my wife, simply saying “I saw a Coke truck driving down the road…..all must be well”. It felt really good that something my team and I had poured everything into was successful.

𝐀𝐧𝐲 𝐪𝐮𝐨𝐭𝐞𝐬 𝐨𝐫 𝐰𝐨𝐫𝐝𝐬 𝐨𝐟 𝐰𝐢𝐬𝐝𝐨𝐦 𝐭𝐡𝐚𝐭 𝐲𝐨𝐮 𝐥𝐢𝐤𝐞? 
Fred DeVito , a well know fitness celebrity, said “If it doesn’t challenge you, it doesn’t change you.”. It’s often used as a quote about running (which is a passion since I was 13 years old), but I think it is relevant for all things in life, both personally and professionally.

#teamrymedi Mark Elfers David Stefanich Deepak H. Elizabeth Yarbrough Jason Cross Armando A. Aditya Tatipaka Shriram S.

Rymedi is proud to announce its partnership with Incora Health to help improve womens' health. 

https://lnkd.in/eZzQzv3w

#blockchain #blockchaintechonology #womenshealth #web3 #desci #diagnostictesting #devicetesting #rymedi #incorahealth
Lindsey Calcutt, PhD Theresa Gevaert David Stefanich Jason Cross Armando A. Samuel Mooney Aditya Tatipaka Shriram S. Sergii Babikov Elizabeth Yarbrough Jim Bickelhaupt

COM:RYMEDI

Rymedi

Analysis Not Available